'High hopes for treatment': Australian stakeholder perspectives of the clinical translation of advanced neurotherapeutics for rare neurological diseases.

MLA

Nguyen, Christina Q., et al. “‘High Hopes for Treatment’: Australian Stakeholder Perspectives of the Clinical Translation of Advanced Neurotherapeutics for Rare Neurological Diseases.” Health Expectations, vol. 27, no. 3, June 2024, pp. 1–15. EBSCOhost, https://doi.org/10.1111/hex.14063.

APA

Nguyen, C. Q., Kariyawasam, D. S. T., Ngai, T. S. J., Nguyen, J., Alba, C. K., Grattan, S. E., Palmer, E. E., Hetherington, K., Wakefield, C. E., Dale, R. C., Woolfenden, S., Mohammad, S., & Farrar, M. A. (2024). “High hopes for treatment”: Australian stakeholder perspectives of the clinical translation of advanced neurotherapeutics for rare neurological diseases. Health Expectations, 27(3), 1–15. https://doi.org/10.1111/hex.14063

Chicago

Nguyen, Christina Q., Didu S. T. Kariyawasam, Tsz Shun Jason Ngai, James Nguyen, Concepcion, Kristine Alba, Sarah E. Grattan, Elizabeth E. Palmer, et al. 2024. “‘High Hopes for Treatment’: Australian Stakeholder Perspectives of the Clinical Translation of Advanced Neurotherapeutics for Rare Neurological Diseases.” Health Expectations 27 (3): 1–15. doi:10.1111/hex.14063.